Previous close | 11.75 |
Open | 12.05 |
Bid | 11.15 |
Ask | 12.30 |
Strike | 640.00 |
Expiry date | 2025-01-17 |
Day's range | 12.05 - 12.05 |
Contract range | N/A |
Volume | |
Open interest | 342 |
By Thomas A. Sternberg, CFA, Partner and Dasha Fomina
The market for GLP-1 drugs could soar to $130 billion by 2030
Eli Lilly and Company (NYSE: LLY) announced today that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective July 22, 2024. Seymour currently serves as the chief quality officer for Bristol Myers Squibb and succeeds Johna Norton, whose retirement after 34 years of service was announced earlier this year.